Alcentra Capital (NASDAQ:ABDC) was upgraded by analysts at Raymond James Financial from an “underperform” rating to a “market perform” rating in a report released on Thursday, MarketBeat Ratings reports.

A number of other equities analysts have also weighed in on the company. Rowe lowered Alcentra Capital from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. Keefe, Bruyette & Woods restated a “hold” rating and issued a $9.50 target price on shares of Alcentra Capital in a research note on Friday, November 10th. ValuEngine upgraded Alcentra Capital from a “buy” rating to a “strong-buy” rating in a research note on Friday, December 1st. Finally, UBS Group lowered Alcentra Capital from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $12.83.

Shares of Alcentra Capital (ABDC) traded up $0.24 on Thursday, reaching $8.88. The company had a trading volume of 222,287 shares, compared to its average volume of 111,311. The stock has a market cap of $126.50, a PE ratio of -177.56 and a beta of 0.62. Alcentra Capital has a twelve month low of $7.00 and a twelve month high of $14.73.

Alcentra Capital (NASDAQ:ABDC) last issued its quarterly earnings data on Monday, November 6th. The asset manager reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.01. The business had revenue of $7.61 million for the quarter. Alcentra Capital had a positive return on equity of 11.32% and a negative net margin of 2.25%. equities analysts forecast that Alcentra Capital will post 1.29 EPS for the current year.

Alcentra Capital declared that its Board of Directors has authorized a share repurchase program on Monday, November 6th that allows the company to repurchase $2.50 million in outstanding shares. This repurchase authorization allows the asset manager to purchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

In other Alcentra Capital news, Director Steven H. Reiff bought 6,900 shares of the firm’s stock in a transaction on Monday, November 13th. The shares were acquired at an average cost of $7.23 per share, for a total transaction of $49,887.00. Following the purchase, the director now directly owns 35,246 shares of the company’s stock, valued at $254,828.58. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Paul J. Echausse sold 10,000 shares of the company’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $7.45, for a total value of $74,500.00. Following the completion of the transaction, the director now owns 58,946 shares in the company, valued at $439,147.70. The disclosure for this sale can be found here. Insiders acquired a total of 11,730 shares of company stock worth $83,956 over the last 90 days. Corporate insiders own 4.96% of the company’s stock.

Institutional investors have recently made changes to their positions in the company. Muzinich & Co. Inc. increased its position in shares of Alcentra Capital by 34.7% during the 2nd quarter. Muzinich & Co. Inc. now owns 610,164 shares of the asset manager’s stock valued at $8,292,000 after purchasing an additional 157,251 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its position in shares of Alcentra Capital by 45.6% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 242,865 shares of the asset manager’s stock valued at $3,300,000 after purchasing an additional 76,115 shares during the last quarter. Wasatch Advisors Inc. increased its position in shares of Alcentra Capital by 82.9% during the 3rd quarter. Wasatch Advisors Inc. now owns 34,124 shares of the asset manager’s stock valued at $365,000 after purchasing an additional 15,469 shares during the last quarter. Goldman Sachs Group Inc. bought a new position in shares of Alcentra Capital during the 2nd quarter valued at about $219,000. Finally, Carnegie Capital Asset Management LLC increased its position in shares of Alcentra Capital by 8.1% during the 2nd quarter. Carnegie Capital Asset Management LLC now owns 20,011 shares of the asset manager’s stock valued at $232,000 after purchasing an additional 1,500 shares during the last quarter. Hedge funds and other institutional investors own 32.06% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Raymond James Financial Upgrades Alcentra Capital (ABDC) to Market Perform” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2018/01/14/raymond-james-financial-upgrades-alcentra-capital-abdc-to-market-perform.html.

About Alcentra Capital

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Receive News & Stock Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related stocks with our FREE daily email newsletter.